CSIMarket
 
Immix Biopharma Inc   (IMMX)
Other Ticker:  
 
 

Immix Biopharma Inc's Suppliers Performance

IMMX's Supply Chain

 
IMMX Costs vs Sales of Suppliers Growth

More on IMMX Suppliers






  News about Immix Biopharma Inc Contracts

Charting New Courses: Immix Biopharma's Proposed Public Offering of Common Stock.

In a significant announcement made recently, Immix Biopharma Inc., a clinical-stage biopharmaceutical company pioneering in cell therapies for autoimmune disease, has declared its intention of floating an underwritten public offering of its common stock. This leading-edge move opens up a new chapter in the growth of the company, mapping out an exciting prospective pathway for investors and stakeholders alike. This crucial initiative by the Los Angeles based company, trading under the Nasdaq ticker symbol IMMX, entails the sale of its common stock in an underwritten public offering. Notably, the company is the sole party positioned to vend the common shares under this proposed transaction. As a part of this s...




Immix Biopharma Inc's Comment on Supply Chain









IMMX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Immix Biopharma Inc 40.81 0.00 -8.23 -
SUBTOTAL 0.00 0.00 0.00 -


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com